Considering the results of preclinical studies which show the beneficial effect of TREM2-associated activation of microglia on tau hyperphosphorylation [22,116] and Aβ phagocytosis [32,112], TREM2 could be a valuable therapeutic target in AD. This evidence concerns the gene MAPT and Alzheimer disease.